“Google, should I be worried about the quality of my pills?”
It’s not a question anybody wants to ask, but if you regularly take medication and things don’t feel quite right, it would be an obvious one to type into a search engine. That’s certainly what Elad Yom-Tov from Microsoft Research thought when he set out to investigate whether search queries could be used to predict when a drug might be recalled.
Turns out, they can. To work that out, New Scientist reports that Yom-Tov trained an AI to establish connections between Bing queries made in each U.S. state relating to 300 different drugs and their recall over the course of eight months. Then, for another four months, he tested the AI to see if it could predict when a drug would be recalled by its manufacturer.
His algorithms were able to predict when a drug would be recalled, but only a day or two before it actually happened. “The most indicative attributes for prediction are sudden spikes in query volume about a specific medicine in each state,” Yom-Tov writes in a paper published on arXiv. “Recalls of prescription drugs and those estimated to be of medium-risk are more likely to be identified using search query data.”
It’s not the first time that search engines have been used to investigate drugs and health. In the past, Microsoft has used queries to identify adverse effects of prescription drugs and even spot warning signs of cancer—though Google’s flu tracking famously didn’t go as well as it hoped.
While the technique can only predict recalls a couple of days in advance with accuracy, Yom-Tov tells New Scientist that it could be used as a monitoring tool much further out. Combined with other tests, it could provide drug companies and regulators with another means of detecting when something’s gone wrong with a batch of drugs.
(Read more: arXiv, New Scientist, “Can You Really Spot Cancer Through a Search Engine?”)
This new data poisoning tool lets artists fight back against generative AI
The tool, called Nightshade, messes up training data in ways that could cause serious damage to image-generating AI models.
The Biggest Questions: What is death?
New neuroscience is challenging our understanding of the dying process—bringing opportunities for the living.
Rogue superintelligence and merging with machines: Inside the mind of OpenAI’s chief scientist
An exclusive conversation with Ilya Sutskever on his fears for the future of AI and why they’ve made him change the focus of his life’s work.
How to fix the internet
If we want online discourse to improve, we need to move beyond the big platforms.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.